Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Applied DNA Sciences ( (BNBX) ).
On November 13, 2025, Applied DNA Sciences officially changed its name to BNB Plus Corp., aligning with its new focus on a BNB-based digital asset treasury strategy. The rebranding, which includes a ticker change to BNBX, reflects the company’s commitment to leveraging Binance-native tools for yield generation and capital efficiency. Additionally, Josh Kruger was appointed as Chairman of the Board, signaling a strengthened leadership in decentralized finance (DeFi). This move is expected to enhance the company’s market positioning and unlock new shareholder value as it expands its BNB holdings.
Spark’s Take on BNBX Stock
According to Spark, TipRanks’ AI Analyst, BNBX is a Neutral.
Applied DNA Sciences faces substantial financial and operational challenges, as indicated by declining revenues and net losses. Despite some positive strategic moves, such as focusing on LineaRx, the stock suffers from poor technical indicators and valuation metrics. The company’s ongoing financial struggles and the uncertainties highlighted in the earnings call contribute to a low overall stock score.
To see Spark’s full report on BNBX stock, click here.
More about Applied DNA Sciences
BNB Plus Corp., formerly known as Applied DNA Sciences, operates in the blockchain and digital asset industry. The company focuses on delivering yield-optimized, BNB-based digital asset treasury strategies leveraging the Binance ecosystem. It also continues to commercialize proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Average Trading Volume: 1,334,812
Technical Sentiment Signal: Strong Sell
Current Market Cap: $12.41M
For detailed information about BNBX stock, go to TipRanks’ Stock Analysis page.